liraglutide
| SMILES | CCCCCCCCCCCCCCCC(=O)N[C@H](C(=O)O)CCC(=O)NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)O)CCCNC(=N)N)CCCNC(=N)N)C(C)C)CC(C)C)Cc1c[nH]c2c1cccc2)C)[C@H](CC)C)Cc1ccccc1)CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1[nH]cnc1)N)C)CCC(=O)O)Cc1ccccc1)CO)CC(=O)O)CO)CO)Cc1ccc(cc1)O)CC(C)C)CCC(=O)O)CCC(=O)N)C)C |
| InChIKey | YSDQQAXHVYUZIW-QCIJIYAXSA-N |
Chemical properties
| Hydrogen bond acceptors | 49 |
| Hydrogen bond donors | 54 |
| Rotatable bonds | 130 |
| Molecular weight (Da) | 3748.9 |
Drug properties
| Molecular type | Protein |
| Physiological/Surrogate | Surrogate |
| Approved drug | Yes |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| GLP-1 | GLP1R | Human | Glucagon | B1 | pKd | 5.2 | 5.2 | 5.2 | ChEMBL |
| GLP-1 | GLP1R | Human | Glucagon | B1 | pKi | 8.2 | 8.28 | 8.36 | ChEMBL |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| GLP-1 | GLP1R | Human | Glucagon | B1 | pEC50 | 10.36 | 10.36 | 10.36 | Guide to Pharmacology |
| GLP-1 | GLP1R | Human | Glucagon | B1 | pIC50 | 8.32 | 9.14 | 9.96 | ChEMBL |
| GLP-1 | GLP1R | Human | Glucagon | B1 | pEC50 | 7.47 | 9.0 | 10.28 | ChEMBL |
| GLP-1 | GLP1R | Human | Glucagon | B1 | pEC50 | 7.99 | 7.99 | 7.99 | Drug Central |